miR	B:C2003459
‑221	I:C2003459
targets	O

High	B:C0122111
mobility	I:C0122111
group	I:C0122111
AT	I:C0122111
-	I:C0122111
hook	I:C0122111
2	I:C0122111
to	O
inhibit	O
bleomycin	B:C0005740
‑induced	O
pulmonary	B:C0034069
fibrosis	I:C0034069
by	O
regulating	O
transforming	B:C1704256
growth	I:C1704256
factor	I:C1704256
‑	I:C1704256

β1	I:C1704256
/	O
Smad3	B:C0529119
-	O
induced	O
epithelial	B:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
.	O

MicroRNA	B:C2003459
(	I:C2003459
miR	I:C2003459
)	I:C2003459
-	I:C2003459
221	I:C2003459
plays	O
an	O
essential	O
role	O
in	O
the	O
epithelial	B:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	B:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
.	O

High	B:C0122111
mobility	I:C0122111
group	I:C0122111
AT	I:C0122111
-	I:C0122111
hook	I:C0122111
2	I:C0122111
(	O
High	B:C0122111
mobility	I:C0122111
group	I:C0122111
AT	I:C0122111
-	I:C0122111
hook	I:C0122111
2	I:C0122111
)	O
,	O
is	O
a	O
key	O
regulator	O
of	O
epithelial	B:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
.	O

However	O
,	O
the	O
role	O
of	O
miR‑221	B:C2003459
in	O
pulmonary	B:C0034069
fibrosis	I:C0034069
,	O
and	O
the	O
association	O
between	O
miR‑221	B:C2003459
and	O
High	B:C0122111
mobility	I:C0122111
group	I:C0122111
AT	I:C0122111
-	I:C0122111
hook	I:C0122111
2	I:C0122111
remain	O
largely	O
unknown	O
.	O

For	O
this	O
purpose	O
,	O
we	O
examined	O
the	O
expression	B:C0017262
of	O
miR‑221	B:C1537859
and	O
High	B:C0122111
mobility	I:C0122111
group	I:C0122111
AT	I:C0122111
-	I:C0122111
hook	I:C0122111
2	I:C0122111
in	O
human	B:C0086418
idiopathic	B:C1800706
pulmonary	I:C1800706
fibrosis	I:C1800706
(	O
idiopathic	B:C1800706
pulmonary	I:C1800706
fibrosis	I:C1800706
)	O
tissues	B:C0040300
and	O
pulmonary	B:C0024109
cells	B:C0007634
,	O
namely	O
the	O
adenocarcinoma	B:C0001418
A549	B:C4277577
and	O
human	B:C0086418
bronchial	B:C0599333
epithelium	I:C0599333
(	O
human	B:C0599333
bronchial	I:C0599333
epithelium	I:C0599333
)	O
cell	B:C0682523
lines	I:C0682523
,	O
and	O
found	O
that	O
the	O
expression	B:C0017262
of	O
miR‑221	B:C1537859
was	O
inhibited	O
in	O
both	O
tissues	B:C0040300
and	O
cells	B:C0007634
whereas	O
high	O
mRNA	B:C0035696
and	O
protein	B:C1171362
expression	I:C1171362
of	O
High	B:C0122111
mobility	I:C0122111
group	I:C0122111
AT	I:C0122111
-	I:C0122111
hook	I:C0122111
2	I:C0122111
was	O
observed	O
.	O

Additionally	O
,	O
transforming	B:C1704256
growth	I:C1704256
factor‑	I:C1704256
β1	I:C1704256
(	O
transforming	B:C1704256
growth	I:C1704256
factor	I:C1704256
‑	I:C1704256
β1	I:C1704256
)	O
induced	O
the	O
epithelial	B:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
,	O
characterized	O
by	O
the	O
upregulated	B:C0041904
expression	B:C0600223
of	O
the	O
mesenchymal	B:C0017393
markers	I:C0017393
,	O
namely	O
N‑cadherin	B:C0027215
,	O
vimentin	B:C0042666
,	O
α‑smooth	B:C2716282
muscle	I:C2716282
actin	I:C2716282
,	O
collagen	B:C0041455
I	I:C0041455
and	O
collagen	B:C0009332
III	I:C0009332
,	O
and	O
the	O
downregulated	B:C0013081
expression	B:C0600223
of	O
the	O
epithelial	B:C0017393
marker	I:C0017393
E	B:C0042172
-	I:C0042172
cadherin	I:C0042172
in	O
A549	B:C4277577
and	O
HBE	B:C0014597
cells	I:C0014597
.	O

We	O
then	O
performed	O
transfection	B:C0314641
with	O
miR‑221	B:C2003459
mimics	O
,	O
and	O
found	O
that	O
the	O
expression	B:C1171362
of	O
phosphorylated	B:C1158886
-	O
Smad3	B:C0529119
in	O
miR‑221	B:C1537859
‑	O
overexpressing	B:C0017262
cells	B:C0007634
was	O
significantly	O
downregulated	B:C0013081
,	O
compared	O
with	O
that	O
in	O
the	O
transforming	B:C1704256
growth	I:C1704256
factor	I:C1704256
‑	I:C1704256
β1	I:C1704256
-	O
treated	O
cells	B:C0007634
without	O
transfection	B:C0314641
.	O

Furthermore	O
,	O
the	O
overexpression	B:C0017262
of	O
miR‑221	B:C1537859
decreased	O
the	O
expression	B:C1171362
of	O
High	B:C0122111
mobility	I:C0122111
group	I:C0122111
AT	I:C0122111
-	I:C0122111
hook	I:C0122111
2	I:C0122111
,	O
suppressed	O
the	O
epithelial	B:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
,	O
and	O
inhibited	O
the	O
proliferation	B:C0596290
of	O
A549	B:C4277577
and	O
HBE	B:C0014597
cells	I:C0014597
.	O

High	B:C0122111
mobility	I:C0122111
group	I:C0122111
AT	I:C0122111
-	I:C0122111
hook	I:C0122111
2	I:C0122111
was	O
directly	O
targeted	O
by	O
miR‑221	B:C2003459
which	O
was	O
confirmed	O
by	O
the	O
dual	O
-	O
luciferase	O
reporter	O
gene	B:C0022885
assay	I:C0022885
.	O

Finally	O
,	O
a	O
mouse	B:C2986594
model	I:C2986594
of	O
bleomycin	B:C0005740
(	O
bleomycin	B:C0005740
)	O
‑induced	O
pulmonary	B:C0034069
fibrosis	I:C0034069
was	O
used	O
to	O
confirm	O
the	O
effect	O
of	O
miR‑221	B:C2744274
on	O
epithelial	B:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
.	O

Hematoxylin	B:C0523207
and	I:C0523207
eosin	I:C0523207
staining	I:C0523207
showed	O
that	O
bleomycin	B:C0005740
induced	O
thicker	O
alveolar	B:C0225695
walls	I:C0225695
and	O
more	O
collagen	B:C0009325
deposition	O
,	O
whereas	O
miR‑221	B:C2744274
treatment	O
reduced	O
lung	B:C0034069
fibrosis	I:C0034069
and	O
the	O
tissues	B:C0040300
exhibited	O
thinner	O
alveolar	B:C0225695
walls	I:C0225695
and	O
normal	O
lung	B:C0034051
alveoli	I:C0034051
.	O

Furthermore	O
,	O
the	O
EMT	B:C1523298
process	I:C1523298
was	O
suppressed	O
following	O
miR‑221	B:C2744274
injection	O
.	O

Taken	O
together	O
,	O
these	O
findings	O
sugest	O
that	O
miR‑221	B:C2003459
targets	O

High	B:C0122111
mobility	I:C0122111
group	I:C0122111
AT	I:C0122111
-	I:C0122111
hook	I:C0122111
2	I:C0122111
to	O
inhibit	O
bleomycin	B:C0005740
‑induced	O
pulmonary	B:C0034069
fibrosis	I:C0034069
through	O
the	O
transforming	B:C1704256
growth	I:C1704256
factor	I:C1704256
‑	I:C1704256

β1	I:C1704256
/	O
Smad3	B:C1566798
signaling	B:C0037080
pathway	I:C0037080
.	O

